The Bovine IL-17A polyclonal antibody is unlabeled and has been qualified for use in ELISA and Western blot applications. It is the capture antibody in the Kingfisher Biotech Bovine IL-17A ELISA. The Bovine IL-17A polyclonal antibody was produced in rabbits and is antigen-affinity purified. The reactivity by species is: (Bovine IL-17A - Strong) (Canine IL-17A - Weak) (Caprine IL-17A - Moderate) (Cynomolgus Monkey IL-17A - Weak) (Dolphin IL-17A - Strong) (Equine IL-17A - None) (Feline IL-17A - Moderate) (Ferret IL-17A - Weak) (Guinea Pig IL-17A - Weak) (Human IL-17A - Weak) (Mouse IL-17A - Weak) (Ovine IL-17A - Strong) (Rabbit IL-17A - Weak) (Rat IL-17A - Weak) (Swine IL-17A - Strong). For research use only.
Bovine IL-17A (Interleukin-17A) is a pro-inflammatory cytokine belonging to the IL-17 family that plays a critical role in host defense and inflammatory responses in cattle (Bos taurus). IL-17A is produced primarily by Th17 cells, as well as by γδ T cells-which are abundant in ruminants-and other innate lymphoid cell populations in response to microbial infection and inflammatory stimulation. It acts on epithelial, endothelial, and stromal cells to induce expression of pro-inflammatory cytokines, chemokines (such as CXCL8), and antimicrobial peptides, thereby promoting neutrophil recruitment and enhancing mucosal and barrier immunity. In healthy cattle, basal IL-17A expression is generally low, but levels increase during bacterial and fungal infections, mastitis, respiratory disease, enteric infections, and parasitic challenges. IL-17A has been implicated in immune responses to pathogens such as Mycobacterium bovis, bovine respiratory disease complex agents, and gastrointestinal nematodes. In veterinary and agricultural research, bovine IL-17A serves as an important biomarker of Th17-mediated immunity and neutrophilic inflammation, providing insight into host-pathogen interactions, vaccine responses, and inflammatory disease mechanisms in cattle.